MAIA Biotechnology, Inc. (MAIA) Sof foyda bo'yicha sotuv rentabelligi

MAIA Biotechnology (MAIA) tovar belgisi

MAIA Biotechnology rahbariyati o'pka saratoni bilan kurashish uchun THIO molekulalarini ishlab chiqishni tezlashtirmoqda. Haqiqiy sof foyda marjasining ushbu grafigi GURU.Markets terminalida mavjud bo'lib, u yerda ko'rsatkich 0.00 darajasida turibdi. Kompaniya dori vositalari tijoratlashtirilgunga qadar doimiy tadqiqot xarajatlari bilan daromad olmagan bosqichda qolgan holda, aksiyalar opsion tizimi orqali yetakchi onkologlarni jalb qilmoqda.

MAIA: MAIA Bio Kompaniyaning sof rentabelligi 28.04.2023 - 19.11.2026

MAIA Biotechnology kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:MAIABiotech.com - MAIA
MAIA Biotechnology Inc yetakchi tovari

MAIA Biotechnology uchun sof daromadlilik grafigi tushumning yakuniy foydaga aylanish samaradorligini aks ettiradi. Ushbu ko'rsatkich barcha operatsion, soliq va foiz xarajatlari chegirib tashlanganidan keyingi sof foyda ulushini o'lchaydi. Bunday ko'rsatkich yashirin xarajatlarni, jumladan, ESG chiqindilarini yo'q qilish qoidalariga rioya qilish va arxivlarni raqamlashtirish xarajatlarini ochib beradi. Sotuvlar o'sishi fonida marjaning pasayishi ma'muriy budjet ustidan nazoratning yo'qolganidan dalolat beradi. Investorlar uchun kapital barqarorligini baholash maqsadida ushbu tendentsiyani kuzatib borish juda muhimdir.

Raqobatchilar tahlili

NantKwest (IBRX) - Sof marja|Sof marja Immunocore PLC (IMCR)|Sof foyda bo'yicha sotuv rentabelligi JANX|RCUS - Sof foyda bo'yicha marjinallik|Sof foyda bo'yicha sotuv rentabelligi ZYME (Zymeworks Corp)|Kompaniyaning sof rentabelligi TNGX|Sotuvning sof marjinal rentabelligi IOVA (Iovance Biotherapeutics, Inc.)|Sof foyda normasi IMTX|xencor.com - Sotuvning sof marjinal rentabelligi|Sof marja Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Sof marja|Lyell Immunopharma - Sof foyda normasi|IPHA (innate-pharma.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi pyxisoncology.com|Sof marja cgen.com (CGEN)|IOBT: Sof foyda marjasi|Sutro Biopharma Inc. - Sof foyda bo'yicha sotuv rentabelligi|minktherapeutics.com (INKT) - Sof marja|HOWL: Sof foyda bo'yicha sotuv rentabelligi|Kompaniya sotuv marjasi Immix Biopharma IMMX|ALX Oncology (ALXO) - Sof marja|Sof marja Cue Biopharma, Inc. (CUE)|Sof marja PDS Biotechnology Corporation|Sotuvning sof rentabelligi SONN (sonnetbio.com)|Sotuvning sof marjinal rentabelligi LIMN|Sotuvning sof marjinal rentabelligi Lava Tx (LVTX)|Sotuvning sof marjinal rentabelligi NXTC (NextCure Corporation)|Sof foyda normasi LPTX|INTS - Sof marja|Kompaniya sotuv marjasi Sensei Biotherapeutics Inc SNSE|TOVX: Sotuvning sof marjinal rentabelligi|Sof marja Gritstone Bio (GRTS)|KA (Kineta Corp) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi NEXI (NexImmune Corp)|Sotuvning sof marjinal rentabelligi TSBX|VCNX (Vaccinex, Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi HARP (Harpoon Therapeutics, Inc.)